{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:08:28Z","timestamp":1782846508147,"version":"3.54.5"},"reference-count":35,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cesarean section (CS) requires perioperative antibiotic prophylaxis (PAP) for the prevention of surgical site infections. However, systemic antibiotics during the peripartum period may induce compositional perturbations of the maternal gut microbiome, a system already characterized by reduced resilience. Data on maternal gut microbiome dynamics after CS with PAP are scarce, largely due to logistical and feasibility barriers that limit the participation of pregnant women and new mothers in conventional clinical studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This protocol primarily aims to evaluate the feasibility of a fully decentralized, remote study design for longitudinal gut microbiome research in the peripartum period. Secondary exploratory objectives include the comparative analyses of microbiome composition between CS with PAP and vaginal delivery (VD) without antibiotic exposure to inform future adequately powered studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The MAMA (Microbiome Changes Due to Antibiotic Prophylaxis in Mothers at Birth) study is a prospective, 2-arm observational cohort study conducted entirely off-site. Women in the third trimester of pregnancy were recruited at 2 German level-1 perinatal centers and affiliated outpatient facilities. Participants underwent either CS with PAP (single dose cefuroxime 1.5 g intravenously) or VD without antibiotics. Stool samples were self-collected at home and returned by mail at 3 predefined time points: late pregnancy (T0), 2 to 3 days post partum (T1), and 90\u00b110 days post partum (T2). Primary outcomes are feasibility indicators, including recruitment rate, sample and questionnaire return rates at each time point, adherence to sampling windows, and participant retention across follow-up. Secondary outcomes are exploratory microbiome measures based on 16S rRNA gene sequencing (V3-V4), including alpha diversity indices, beta diversity metrics, and relative taxonomic abundances. Microbiome analyses are explicitly compositional and hypothesis-generating. Group comparisons and longitudinal within-individual changes will be assessed using nonparametric diversity metrics and multivariate distance\u2013based methods. No confirmatory hypothesis testing is planned.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Recruitment occurred between May 2022 and October 2023, with 37 women enrolled (25 CSs and 12 VDs). Follow-up was completed with receipt of the final stool sample in March 2024. DNA extraction and sequencing were completed in a single batch in October 2024. Bioinformatic processing and statistical analyses were initiated in June 2025 and are ongoing as of December 2025. Results from the exploratory microbiome analyses are expected to be published in 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This protocol demonstrates the feasibility of conducting fully decentralized, longitudinal microbiome research in a peripartum population without requiring on-site visits. By integrating study procedures into maternal realities, the remote design reduces participation barriers and addresses a clinically relevant research gap that has remained largely unexamined despite routine use of PAP. While microbiome-related outcomes are exploratory, the methodological framework established here provides a scalable model for future maternal and postpartum research, supporting ethically grounded, participant-centered study designs and evidence-informed care strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/84909","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T20:13:09Z","timestamp":1776888789000},"page":"e84909-e84909","source":"Crossref","is-referenced-by-count":0,"title":["Perioperative Antibiotic Prophylaxis in Cesarean Section and the Maternal Gut Microbiome: Protocol for a Remote Observational Cohort Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9219-1418","authenticated-orcid":false,"given":"Elisabeth AL","family":"Feles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2268-6310","authenticated-orcid":false,"given":"Frauke","family":"Mattner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"R1","unstructured":"Caesarean section rates continue to rise, amid growing inequalities in access: rising rates suggest increasing numbers of medically unnecessary, potentially harmful procedures. World Health Organization. Jun 16, 2021. URL: https:\/\/www.who.int\/news\/item\/16-06-2021-caesarean-section-rates-continue-to-rise-amid-growing-inequalities-in-access [Accessed 31-01-2026]"},{"key":"R2","unstructured":"Global guidelines for the prevention of surgical site infection. World Health Organization; 2018. URL: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/5c422323-5c27-4e6a-812e-dbd76023ba48\/content [Accessed 31-01-2026]"},{"issue":"3","key":"R3","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1097\/AOG.0000000000002833","article-title":"ACOG Practice Bulletin No. 199: use of prophylactic antibiotics in labor and delivery","volume":"132","author":"Committee on Practice Bulletins-Obstetrics","journal-title":"Obstet Gynecol"},{"key":"R4","unstructured":"S3-leitlinie die sectio caesarea [Report in German]. AWMF \u2013 arbeitsgemeinschaft der wissenschaftlichen medizinischen fachgesellschaften; URL: https:\/\/register.awmf.org\/assets\/guidelines\/015-084m_S3_Sectio-caesarea_2020-06_1_02.pdf [Accessed 31-01-2026]"},{"key":"R5","unstructured":"WHO recommendation on prophylactic antibiotics for women undergoing caesarean section. World Health Organization; 2021. URL: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/314369b7-1c7f-4b59-a448-4770ddd20d85\/content [Accessed 31-01-2026]"},{"key":"R6","unstructured":"Cefuroxim\u2011saar\u00ae 750 mg \/ 1500 mg [Article in German]. Rote Liste. URL: https:\/\/www.fachinfo.de\/fi\/detail\/020332\/cefuroxim-saar-r-750-mg-1500-mg [Accessed 31-01-2026]"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.959903","article-title":"Oral antibiotics perturbation on gut microbiota after prostate biopsy","volume":"12","author":"Li","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"R8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4269\/ajtmh.23-0651","article-title":"Gut microbiome diversity and antimicrobial resistance after a single dose of oral azithromycin in children: a randomized placebo\u2011controlled trial","volume":"110","author":"Doan","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"R9","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.cell.2012.07.008","article-title":"Host remodeling of the gut microbiome and metabolic changes during pregnancy","volume":"150","author":"Koren","journal-title":"Cell"},{"issue":"3","key":"R10","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.01252-23","article-title":"Multi-omics analysis reveals the associations between altered gut microbiota, metabolites, and cytokines during pregnancy","volume":"9","author":"Huang","journal-title":"mSystems"},{"issue":"1","key":"R11","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12010127","article-title":"The in vitro efficacy of activated charcoal in fecal ceftriaxone adsorption among patients who received intravenous ceftriaxone","volume":"12","author":"Torvorapanit","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"R12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3109\/00365548509070424","article-title":"Ceftriaxone: pharmacokinetics and effect on the intestinal microflora in patients with acute bacterial infections","volume":"17","author":"Nilsson-Ehle","journal-title":"Scand J Infect Dis"},{"issue":"Suppl 9","key":"R13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/00359157770700S920","article-title":"Biliary tract excretion of cefuroxime","volume":"70","author":"Sales","journal-title":"Proc R Soc Med"},{"issue":"2","key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.105959","article-title":"Exploring the roles of intestinal flora in enhanced recovery after surgery","volume":"26","author":"Liu","journal-title":"iScience"},{"issue":"11","key":"R15","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11112099","article-title":"Current insights: the impact of gut microbiota on postoperative complications in visceral surgery-a narrative review","volume":"11","author":"Lederer","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"R16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7861\/clinmedicine.18-3-237","article-title":"infection and antibiotic-associated diarrhoea","volume":"18","author":"Mullish","journal-title":"Clin Med (Lond)"},{"issue":"1","key":"R17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jhin.2006.05.006","article-title":"Prophylactic antibiotics and Clostridium difficile infection","volume":"64","author":"Mukhtar","journal-title":"J Hosp Infect"},{"issue":"14","key":"R18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14145104","article-title":"Impact of perioperative antibiotic prophylaxis in caesarean section on the maternal gut microbiome: a systematic review","volume":"14","author":"Feles","journal-title":"J Clin Med"},{"issue":"1","key":"R19","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.01202-20","article-title":"Primer, pipelines, parameters: issues in 16S rRNA gene sequencing","volume":"6","author":"Abellan-Schneyder","journal-title":"mSphere"},{"issue":"2","key":"R20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264443","article-title":"Ranking the biases: the choice of OTUs vs. ASVs in 16S rRNA amplicon data analysis has stronger effects on diversity measures than rarefaction and OTU identity threshold","volume":"17","author":"Chiarello","journal-title":"PLoS ONE"},{"issue":"1","key":"R21","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-025-02570-w","article-title":"Barriers and strategies for recruitment of pregnant women in contemporary longitudinal birth cohort studies","volume":"25","author":"Rokicki","journal-title":"BMC Med Res Methodol"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-204","article-title":"Feasibility of self-collection of fecal specimens by randomly sampled women for health-related studies of the gut microbiome","volume":"7","author":"Feigelson","journal-title":"BMC Res Notes"},{"issue":"4","key":"R23","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1007\/s00248-019-01346-2","article-title":"A customized at\u2011home stool collection protocol for use in microbiome studies conducted in cancer patient populations","volume":"78","author":"Hogue","journal-title":"Microb Ecol"},{"issue":"10","key":"R24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","journal-title":"PLoS Med"},{"issue":"8","key":"R25","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","journal-title":"Nat Biotechnol"},{"issue":"10","key":"R26","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41592-018-0141-9","article-title":"Qiita: rapid, web-enabled microbiome meta-analysis","volume":"15","author":"Gonzalez","journal-title":"Nat Methods"},{"issue":"2","key":"R27","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00191-16","article-title":"Deblur rapidly resolves single\u2011nucleotide community sequence patterns","volume":"2","author":"Amir","journal-title":"mSystems"},{"issue":"5","key":"R28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41587-023-01845-1","article-title":"Greengenes2 unifies microbial data in a single reference tree","volume":"42","author":"McDonald","journal-title":"Nat Biotechnol"},{"issue":"3","key":"R29","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/ismej.2011.139","article-title":"An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea","volume":"6","author":"McDonald","journal-title":"ISME J"},{"issue":"1","key":"R30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1046\/j.1442-9993.2001.01070.x","article-title":"A new method for non-parametric multivariate analysis of variance","volume":"26","author":"Anderson","journal-title":"Austral Ecol"},{"issue":"1","key":"R31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17041-7","article-title":"Analysis of compositions of microbiomes with bias correction","volume":"11","author":"Lin","journal-title":"Nat Commun"},{"issue":"16","key":"R32","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19169961","article-title":"Changes in the gut microbiome and pathologies in pregnancy","volume":"19","author":"Gorczyca","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"R33","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1161\/CIRCRESAHA.122.320771","article-title":"Gut dysbiosis promotes preeclampsia by regulating macrophages and trophoblasts","volume":"131","author":"Jin","journal-title":"Circ Res"},{"issue":"12","key":"R34","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00592-017-1056-0","article-title":"Gut microbiota aberrations precede diagnosis of gestational diabetes mellitus","volume":"54","author":"Mokkala","journal-title":"Acta Diabetol"},{"issue":"13","key":"R35","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13133875","article-title":"Vaginal microbiome and pregnancy complications: a review","volume":"13","author":"Gerede","journal-title":"J Clin Med"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e84909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:19:00Z","timestamp":1782843540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e84909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":35,"URL":"https:\/\/doi.org\/10.2196\/84909","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"v15i3e84909"}}